Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract shedding

C Johnston, L Corey - Clinical microbiology reviews, 2016 - Am Soc Microbiol
SUMMARY Herpes simplex virus 2 (HSV-2) is a DNA virus that is efficiently transmitted
through intimate genital tract contact and causes persistent infection that cannot be …

Genital herpes

SM Garland, M Steben - Best Practice & Research Clinical Obstetrics & …, 2014 - Elsevier
Genital herpes is a relatively common infection caused by herpes simplex virus (HSV) type
one or two (HSV-1, HSV-2) respectively. It is acquired most commonly via sexual activity …

Viral infections

JC Sterling - Rook's Textbook of Dermatology, Ninth Edition, 2016 - Wiley Online Library
Skin disease due to viruses may be a primary infection of the epidermis or may arise
secondary to systemic infection. Depending on the virus, the effects may be necrotic damage …

Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published …

KJ Looker, NJ Welton, KM Sabin, S Dalal… - The Lancet Infectious …, 2020 - thelancet.com
Background A 2017 systematic review and meta-analysis of 55 prospective studies found
the adjusted risk of HIV acquisition to be at least tripled in individuals with herpes simplex …

Helicase–primase inhibitor pritelivir for HSV-2 infection

A Wald, L Corey, B Timmler, A Magaret… - … England Journal of …, 2014 - Mass Medical Soc
Background Pritelivir, an inhibitor of the viral helicase–primase complex, exhibits antiviral
activity in vitro and in animal models of herpes simplex virus (HSV) infection. We tested the …

Rapid host immune response and viral dynamics in herpes simplex virus-2 infection

JT Schiffer, L Corey - Nature medicine, 2013 - nature.com
Abstract Herpes simplex virus-2 (HSV-2) is periodically shed throughout the human genital
tract. Although a high viral load correlates with the development of genital ulcers, shedding …

Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance

SH James, MN Prichard - Current opinion in virology, 2014 - Elsevier
Highlights•We review the current state of anti-HSV chemotherapy, including resistance
rates.•We highlight novel agents under investigation for the treatment of HSV …

Safety, formulation and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1

NI Torres, KS Noll, S Xu, J Li, Q Huang… - Probiotics and …, 2013 - Springer
In the present study, the antiviral properties of the bacteriocin subtilosin against Herpes
simplex virus type 1 (HSV-1) and the safety and efficacy of a subtilosin-based nanofiber …

Effect of pritelivir compared with valacyclovir on genital HSV-2 shedding in patients with frequent recurrences: a randomized clinical trial

A Wald, B Timmler, A Magaret, T Warren, S Tyring… - Jama, 2016 - jamanetwork.com
Importance Current therapy of herpes infections relies on nucleoside analogues. Pritelivir is
a well-tolerated novel herpes simplex virus (HSV) helicase-primase inhibitor that reduced …

Genital herpes infection: progress and problems

N Van Wagoner, F Qushair… - Infectious Disease Clinics, 2023 - id.theclinics.com
Genital herpes (GH) is caused by 2 related yet distinct viruses: herpes simplex viruses (HSV)
type-1 (HSV-1) and type-2 (HSV-2). 1 In 2016, there were an estimated 491.5 million people …